Paper4159616
Treatment of chronic portal-systemic encephalopathy with lactulose.
Bircher J and 3 others. Lancet, 1966. Cited by 209 papers, by iCite.
Cite this record
ConductScience Library. Treatment of chronic portal-systemic encephalopathy with lactulose. Papers, record 4159616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4159616
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Diseases | Major topic |
| Disaccharides | Major topic |
| Liver Cirrhosis | Major topic |
| Diet Therapy | |
| Dietary Proteins | |
| Humans | |
| Male | |
| Middle Aged | |
| Neomycin | |
| Sorbitol |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40348498 | Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis. | Gastroenterol Clin North Am | 2025 | https://conductscience.org/library/papers/40348498 | PubMed |
| 39398174 | Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs. | ACS Omega | 2024 | https://conductscience.org/library/papers/39398174 | PubMed |
| 39397831 | Review of history and mechanisms of action of lactulose (4-O-β-D-Galactopyranosyl-β-D-fructofuranose): present and future applications in food. | J Food Sci Technol | 2024 | https://conductscience.org/library/papers/39397831 | PubMed |
| 39212845 | Infection, inflammation and hepatic encephalopathy from a clinical perspective. | Metab Brain Dis | 2024 | https://conductscience.org/library/papers/39212845 | PubMed |
| 38548443 | Future Therapies of Hepatic Encephalopathy. | Clin Liver Dis | 2024 | https://conductscience.org/library/papers/38548443 | PubMed |
| 38239765 | Interaction of Organogermanium Compounds with Saccharides in Aqueous Solutions: Promotion of Aldose-to-ketose Isomerization and Its Molecular Mechanism. | J Appl Glycosci (1999) | 2023 | https://conductscience.org/library/papers/38239765 | PubMed |
| 37467180 | Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37467180 | PubMed |
| 36070941 | Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. | Intern Med | 2023 | https://conductscience.org/library/papers/36070941 | PubMed |
| 35460476 | Neurological monitoring and sedation protocols in the Liver Intensive Care Unit. | Metab Brain Dis | 2022 | https://conductscience.org/library/papers/35460476 | PubMed |
| 34745583 | A Brief History of Hepatic Encephalopathy. | Clin Liver Dis (Hoboken) | 2021 | https://conductscience.org/library/papers/34745583 | PubMed |
| 34429690 | Efficient Continuous Production of Lactulose Syrup by Alkaline Isomerization Using an Organogermanium Compound. | J Appl Glycosci (1999) | 2019 | https://conductscience.org/library/papers/34429690 | PubMed |
| 34354493 | Efficient Alkaline Isomerization of Lactose to Lactulose in the Presence of an Organogermanium Compound. | J Appl Glycosci (1999) | 2017 | https://conductscience.org/library/papers/34354493 | PubMed |
| 32655239 | The Current Hepatic Encephalopathy Pipeline. | J Clin Exp Hepatol | 2020 | https://conductscience.org/library/papers/32655239 | PubMed |
| 31686894 | Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis. | Int J Gen Med | 2019 | https://conductscience.org/library/papers/31686894 | PubMed |
| 30857316 | Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. | Foods | 2019 | https://conductscience.org/library/papers/30857316 | PubMed |
| 30643982 | Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study. | J Gastroenterol | 2019 | https://conductscience.org/library/papers/30643982 | PubMed |
| 30586410 | Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease. | PLoS One | 2018 | https://conductscience.org/library/papers/30586410 | PubMed |
| 29872332 | A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans. | Clin Exp Gastroenterol | 2018 | https://conductscience.org/library/papers/29872332 | PubMed |
| 29849776 | Identification of modules of hepatic encephalopathy based on protein-protein network and gene expression data. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29849776 | PubMed |
| 29297141 | Lactulose: A Simple Sugar in a Complex Encephalopathy. | Neurocrit Care | 2018 | https://conductscience.org/library/papers/29297141 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4159616
GET https://conductscience.org/api/papers/v1/4159616/cited_by?page=2